4.5 Article

Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK

Journal

BMC PREGNANCY AND CHILDBIRTH
Volume 22, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12884-021-04321-3

Keywords

-

Funding

  1. Imperial College COVID-19 Research Fund
  2. National Institute for Health Research (NIHR), doctoral research fellowship [NIHR300907]
  3. IMmunising PRegnant women and INfants neTwork (IMPRINT) - UK Research and Innovation-Global Challenges Research Fund Networks in Vaccines Research and Development
  4. Medical Research Council
  5. Biotechnology and Biological Sciences Research Council
  6. MRC [MC_UP_A900/1122, MC_UP_A900/115]
  7. National Institute for Health Research Health Protection Research Unit (NIHR HPRU)) in Immunisation at the London School of Hygiene and Tropical Medicine (LSHTM)
  8. Public Health England (PHE)
  9. National Institutes of Health Research (NIHR) [NIHR300907] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

This study investigated the acceptability of COVID-19 vaccines among pregnant women and found higher acceptance rates when not pregnant compared to during pregnancy and for their babies. Income, ethnicity, and previous vaccination against pertussis were identified as the main drivers influencing vaccine decision-making.
Background: COVID-19 vaccines are advised for pregnant women in the United Kingdom (UK) however COVID-19 vaccine uptake among pregnant women is inadequate. Methods: An online survey and semi-structured interviews were used to investigate pregnant women's views on COVID-19 vaccine acceptability for themselves when pregnant, not pregnant and for their babies. One thousand one hundred eighty-one women, aged over 16 years, who had been pregnant since 23rd March 2020, were surveyed between 3rd August-11th October 2020. Ten women were interviewed. Results: The majority of women surveyed (81.2%) reported that they would 'definitely' or were 'leaning towards' accepting a COVID-19 vaccine when not pregnant. COVID-19 vaccine acceptance was significantly lower during pregnancy (62.1%, p < 0.005) and for their babies (69.9%, p <0.005). Ethnic minority women were twice as likely to reject a COVID-19 vaccine for themselves when not pregnant, pregnant and for their babies compared to women from White ethnic groups (p < 0.005). Women from lower-income households, aged under 25-years, and from some geographic regions were more likely to reject a COVID-19 vaccine when not pregnant, pregnant and for their babies. Multivariate analysis revealed that income and ethnicity were the main drivers of the observed age and regional differences. Women unvaccinated against pertussis in pregnancy were over four times more likely to reject COVID-19 vaccines when not pregnant, pregnant and for their babies. Thematic analysis of the survey freetext responses and interviews found safety concerns about COVID-19 vaccines were common though wider mistrust in vaccines was also expressed. Trust in vaccines and the health system were also reasons women gave for accepting COVID-19 vaccines. Conclusion: Safety information on COVID-19 vaccines must be clearly communicated to pregnant women to pro-vide reassurance and facilitate informed pregnancy vaccine decisions. Targeted interventions to promote COVID-19 vaccine uptake among ethnic minority and lower-income women may be needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available